About SOPHiA GENETICS
SOPHiA GENETICS news and updates
Sophia Genetics partnered with Hiroshima University on Mar 1st 21'.
BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with Hiroshima University, one of the top public universities in Hiroshima City, Japan, to support their molecular profiling by next-generation sequencing (NGS) in investigating the pathogenic variants causing different blood cancer disorders.
Jan 1, 2022 | lifecarenews.inSophia Genetics launched SOPHiA DDM Homologous Recombination Deficiency Solution on Feb 24th 22'.
SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, announced today the launch of their SOPHiA DDM Homologous Recombination Deficiency (HRD) Solution, opening new doors for cancer research.
Jan 1, 2022 | prnewswire.comSOPHiA GENETICS SA launches deep learning-based application on Data-Driven Medicine
Sophia Genetics has introduced a deep learning-based application on its Data-Driven Medicine (DDM) platform for detecting homologous recombination deficiency (HRD).
Jan 1, 2022 | genomeweb.com360 Capital Partners invests into SOPHiA GENETICS SA in $30M
Sophia Genetics, a big data analytics company that’s using artificial intelligence (AI) to help medical professionals diagnose and treat patients through genomic analysis, has raised $30 million in a round of funding led by Balderton Capital, with participation from 360 Capital Partners, Invoke Capital, and Alychlo.
Jan 1, 2017 | venturebeat.comElise leaves SOPHiA GENETICS SA as Vice President Asia Pacific
Elise joins Aim Lab from SOPHiA GENETICS where she was Vice President Asia Pacific responsible for establishing and expanding the regional operations.
Jan 1, 2022 | aimlab.comSOPHiA GENETICS SA received financing of $140M in funding round on Jan 4th 19'.
With the new funding round, SOPHiA GENETICS has now raised a total of $140 million.
Jan 1, 2019 | prnewswire.comIverson leaves SOPHiA GENETICS SA as VP of global marketing
Iverson joins the company from Sophia Genetics, where he served as VP of global marketing.
Jan 1, 2022 | genomeweb.comSOPHiA GENETICS SA partnered with Diagnóstica Longwood SL on Jun 9th 22'.
Sophia Genetics said Thursday that it has teamed with the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona, Spain, and Spanish molecular diagnostics firm Diagnóstica Longwood to introduce a new software tool for chronic lymphocytic leukemia (CLL) analysis.
Jan 1, 2022 | genomeweb.comSOPHiA GENETICS SA launches SOPHiA DDM Dispatch
SOPHiA GENETICS is proud to announce the launch of SOPHiA DDM™ Dispatch.
Aug 21, 2022 | sophiagenetics.comSOPHiA GENETICS SA partners with Boundless Bio
SOPHiA GENETICS announced a partnership with Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers.
Sep 20, 2022 | sophiagenetics.com